RemedyRePack Inc. recalls
4 notices naming RemedyRePack Inc. as the recalling firm, since January 1, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
RemedyRePack Inc.: Clindamycin HCl Capsule
Hazard (FDA): CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
FDAMedicines
RemedyRepack Inc.: Carvedilol 25 mg Tablet
Hazard (FDA): CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
FDAMedicines
RemedyRepack Inc.: Duloxetine Delayed-Release Capsules
Hazard (FDA): CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
FDAMedicines